Suffering from prostate cancer or benign prostatic hyperplasia (BPH) is not the end of a relationship. Technology and ...

OXFORD, UK / ACCESS Newswire / June 15, 2026 /Fine Treatment has highlighted increasing interest in non-invasive therapeutic ...

The prevalence of benign prostatic hyperplasia is increasing globally, according to a study published online Oct. 20 in The Lancet Healthy Longevity. Atalel Fentahun Awedew, M.D., from Addis Ababa ...

Patients with gout, especially those younger than 60 years, have an increased risk for benign prostatic hyperplasia (BPH), according to a study published online Dec. 26 in Diagnostics. Woo Jin Bang, ...

An enlarged prostate—also known as benign prostatic hyperplasia (BPH)—is a natural sign of aging that affects half of all men over the age of 40. The good news is this condition does not increase your ...

Frequent urination, urgency and waking up at night to urinate are often blamed on an enlarged prostate. However, doctors say ...

Classically, transurethral resection of the prostate (TURP) has been the gold standard for benign prostatic hyperplasia (BPH) surgery. From 2013 to 2019, in the United States Medicare population, ...

Human ejaculation can be defined as a complex and still largely unknown function. Since decades, Benign Prostatic Hyperplasia (BPH) surgery-associated loss of antegrade ejaculation has been reported ...

(NASDAQ: ANGO), a medical technology company focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options and improving patient quality of life, today ...

Contemporary diagnosis of very low risk prostate cancer in a multi-centered hospital system. Use of the Prostatype P-score to predict adverse pathology (AP) at radical prostatectomy (RP). This is an ...

Fine Treatment participates in many meetings and conferences in the UK, including most recently the Oxford Innovation ...